Molecular Insight gains on Onalta data

Molecular Insight Pharmaceuticals Inc. (NASDAQ:MIPI) jumped $1.93 (129%) to $3.43 on Tuesday after a Monday evening press release highlighted data published last month for its Onalta edotreotide. In a...